Skip to main content
. Author manuscript; available in PMC: 2021 May 5.
Published in final edited form as: Circulation. 2020 Apr 2;141(18):1463–1476. doi: 10.1161/CIRCULATIONAHA.119.045323

Figure 3. Risk of adverse outcomes among Penn Heart Failure Study participants with HFpEF stratified by tertiles of APOM.

Figure 3.

Figure 3.

Kaplan-Meier survival curves for all-cause mortality (A) or the composite outcome of death or heart failure-related hospitalization (B) are shown. The number of patients at risk at each timepoint is presented below the graph.